BFC Planning’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Other funds holding RLAY
SL
BFC Planning's RLAY Position: Q3 2026 in Review
BFC Planning opened a new position in Relay Therapeutics (RLAY) in Q3 2026: 31 shares worth $560. The stake represents ﹤0.01% of the portfolio and ranks #3277 among its holdings.
183 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.
- BFC Planning held 31 shares of Relay Therapeutics worth $560 as of Q3 2026.
- Relay Therapeutics was a new BFC Planning position in Q3 2026.
- Relay Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3277 holding.
- 183 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.